{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:40:31Z","timestamp":1764002431486,"version":"3.41.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To examine whether there is heterogeneity in the risk factors for skin cancer among the high-risk population in Slovenia, a Central European country with the second-largest age-standardized melanoma-related mortality rate in Europe.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed data collected during the \u2018Euromelanoma Day\u2019 2010\u20132019. The outcome was the prevalence of newly suspected skin cancer. The independent variables were 17 known risk factors and protective behaviors. We performed a latent class analysis with skin cancer as a covariate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We analyzed data from 1711 participants with a median (interquartile range) age of 52 (39\u201363)\u2009years, 52% of whom were women. During the 10\u2009years, 81 cases of melanoma and 213 cases of other skin cancers were suspected. The model with three latent classes had the best fit. Two latent classes had a high risk for melanoma and other skin cancer: 3 and 19% respectively in class 2; 14 and 29% in class 3. The largest significant differences between the two high-risk classes were the older age and lower frequency of sunscreen use in high-risk class 2 and the number of atypical nevi, a large number of common moles, many moles as the primary motive to participate in Euromelanoma examination and having a skin phototype I or II in the highest-risk latent class 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There is heterogeneity in the risk factors for skin cancer among the Euromelanoma high-risk population. This heterogeneity should be tested in other countries, and if the findings are consistent, they should be used to refine secondary prevention programs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000679","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T21:09:58Z","timestamp":1619471398000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The heterogeneity of population with high risk for melanoma and other skin cancer: a latent class analysis"],"prefix":"10.1097","volume":"31","author":[{"given":"Larisa","family":"Stojanovi\u0107","sequence":"first","affiliation":[{"name":"Institute of Anatomy, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u017darko","family":"Baji\u0107","sequence":"additional","affiliation":[{"name":"Research Unit \u2018Dr. Mirko Grmek\u2019, University Psychiatric Hospital \u2018Sveti Ivan\u2019, Zagreb, Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-019-05443-3","article-title":"Screening for melanoma in men: a cost-effectiveness analysis.","volume":"35","author":"Adamson","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/CMR.0b013e328363b015","article-title":"Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality.","volume":"23","author":"Bordoni","year":"2013","journal-title":"Melanoma Res"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/1055-9965.EPI-10-0196","article-title":"Predictors of sun protection behaviors and severe sunburn in an international online study.","volume":"19","author":"Br\u00e4nstr\u00f6m","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaad.2016.07.045","article-title":"Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: a systematic review.","volume":"76","author":"Brunssen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-3083.2007.02316.x","article-title":"Evaluation of the Euromelanoma skin cancer screening campaign: the Swiss experience.","volume":"22","author":"Bulliard","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"R6-20250527","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2133.2012.11091.x","article-title":"Effectiveness of skin cancer screening programmes.","volume":"167","author":"Choudhury","year":"2012","journal-title":"Br J Dermatol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/CMR.0000000000000104","article-title":"Screening for melanoma.","volume":"24","author":"Collins","year":"2014","journal-title":"Melanoma Res"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1111\/ijd.14179","article-title":"Euromelanoma in Portugal. How useful was the Euromelanoma campaign between 2010 and 2017?","volume":"57","author":"Correia","year":"2018","journal-title":"Int J Dermatol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bjd.18524","article-title":"A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.","volume":"182","author":"Cust","year":"2020","journal-title":"Br J Dermatol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"105829","DOI":"10.1016\/j.ypmed.2019.105829","article-title":"Skin cancer screening in Switzerland: cross-sectional trends (1997\u20132012) in socioeconomic inequalities.","volume":"129","author":"Dumont","year":"2019","journal-title":"Prev Med (Baltim)"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0969141317734003","article-title":"Observed and expected mortality in the German skin cancer screening pilot project SCREEN.","volume":"25","author":"Eisemann","year":"2018","journal-title":"J Med Screen"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1002\/cam4.2252","article-title":"Melanoma incidence, recurrence, and mortality in an integrated healthcare system: a retrospective cohort study.","volume":"8","author":"Feigelson","year":"2019","journal-title":"Cancer Med"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018.","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jamaoncol.2016.6779","article-title":"A large skin cancer screening quality initiative.","volume":"3","author":"Ferris","year":"2017","journal-title":"JAMA Oncol"},{"journal-title":"Cancer Incid five Cont Time Trends","article-title":"Sex-age-specific incidence tables by cancer for a selected population and yar or period.","year":"2012","key":"R15-20250527"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bjd.13500","article-title":"Socioeconomic and lifestyle factors and melanoma: a systematic review.","volume":"172","author":"Jiang","year":"2015","journal-title":"Br J Dermatol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10198-017-0888-4","article-title":"The effectiveness of a population-based skin cancer screening program: evidence from Germany.","volume":"19","author":"Kaiser","year":"2018","journal-title":"Eur J Health Econ"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1002\/cncr.27566","article-title":"Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.","volume":"118","author":"Katalinic","year":"2012","journal-title":"Cancer"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41588-020-0611-8","article-title":"Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility.","volume":"52","author":"Landi","year":"2020","journal-title":"Nat Genet"},{"key":"R21-20250527","first-page":"w14511","article-title":"Evaluation of the National Skin Cancer Campaign: a Swiss experience of Euromelanoma.","volume":"147","author":"Lieberherr","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaad.2018.05.1242","article-title":"The first 30 years of the American academy of dermatology skin cancer screening program: 1985-2014.","volume":"79","author":"Okhovat","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1468-3083.2009.03316.x","article-title":"Results of the \u2018Euromelanoma Day\u2019 screening campaign in Sweden 2008.","volume":"23","author":"Paoli","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2340\/00015555-2944","article-title":"Effect of age on melanoma risk, prognosis and treatment response.","volume":"98","author":"Ribero","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2188\/jea.JE20160166","article-title":"Patterns of ultraviolet radiation exposure and skin cancer risk: the E3N-SunExp Study.","volume":"28","author":"Savoye","year":"2018","journal-title":"J Epidemiol"},{"key":"R26-20250527","first-page":"608","article-title":"Effectiveness of skin cancer screening for individuals age 14 to 34 years.","volume":"9","author":"Schmitt","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/CEJ.0b013e3283498e14","article-title":"Italian Euromelanoma Day Screening Campaign (2005\u20132007) and the planning of melanoma screening strategies.","volume":"21","author":"Seidenari","year":"2012","journal-title":"Eur J Cancer Prev"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cncr.29755","article-title":"Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.","volume":"122","author":"Stang","year":"2016","journal-title":"Cancer"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10654-017-0348-6","article-title":"Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000\u20132015).","volume":"33","author":"Stang","year":"2018","journal-title":"Eur J Epidemiol"},{"issue":"Suppl 2","key":"R30-20250527","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.2012.11092.x","article-title":"Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.","volume":"167","author":"Stratigos","year":"2012","journal-title":"Br J Dermatol"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1468-3083.2006.01865.x","article-title":"Melanoma\/skin cancer screening in a Mediterranean country: results of the Euromelanoma screening day campaign in Greece.","volume":"21","author":"Stratigos","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-4632.2012.05783.x","article-title":"The Italian Euromelanoma day: evaluation of results and implications for future prevention campaigns.","volume":"53","author":"Suppa","year":"2014","journal-title":"Int J Dermatol"},{"issue":"Suppl 2","key":"R33-20250527","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.15311","article-title":"Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign.","volume":"33","author":"Suppa","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.amjmed.2019.10.008","article-title":"Advances in prevention and surveillance of cutaneous malignancies.","volume":"133","author":"Trager","year":"2020","journal-title":"Am J Med"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14758","article-title":"Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.","volume":"175","author":"Trautmann","year":"2016","journal-title":"Br J Dermatol"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1468-3083.2011.04228.x","article-title":"The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.","volume":"25","author":"van der Leest","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1468-3083.2000.00127.x","article-title":"Melanoma screening: results of the first one-day campaign in Belgium (\u2018melanoma Monday\u2019).","volume":"14","author":"Vandaele","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1634\/theoncologist.2018-0093","article-title":"Expenditures on oncology drugs and cancer mortality-to-incidence ratio in central and Eastern Europe.","volume":"24","author":"Vrdoljak","year":"2019","journal-title":"Oncologist"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.19010","article-title":"Trends in malignant melanoma mortality in 31 countries from 1985 to 2015.","volume":"183","author":"Yang","year":"2020","journal-title":"Br J Dermatol"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/raon-2017-0008","article-title":"Cancer burden in slovenia with the time trends analysis.","volume":"51","author":"Zadnik","year":"2017","journal-title":"Radiol Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:06:55Z","timestamp":1748362015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000679","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}